Ran Nussbaum
Angel · New York
Board director at 3 startups that filed Form D raises since late 2024, mostly in New York.
- Stages
- Series A, Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Dec 2023
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: UroGen PharmaAug 14, 2023
- SEC Form D: LB PharmaceuticalsSep 21, 2023
- SEC Form D: Graviton BioScienceDec 4, 2023
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.